Status:

TERMINATED

An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia

Lead Sponsor:

Xian-Janssen Pharmaceutical Ltd.

Conditions:

Schizophrenia

Eligibility:

All Genders

18-65 years

Brief Summary

The purpose of this study is to evaluate the long-term treatment efficacy, and safety of risperidone long-acting injection in participants with schizophrenia (psychiatric disorder with symptoms of emo...

Detailed Description

This is an open-label (all people know the identity of the intervention), multi-center (conducted in more than one center), prospective (study following participants forward in time) and observational...

Eligibility Criteria

Inclusion

  • Male or female, age 18-65 years
  • Participant must meet the diagnostic criteria for schizophrenia or schizophreniform disorder according to Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV)-TM
  • Total course of disease no more than 5 years
  • According to physician's discretion, participants need to be changed to risperidone long-acting injection and other atypical anti-psychotic drug
  • Participant or their legally acceptable representatives must have signed an informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study

Exclusion

  • Significant risk of suicidal or violent behavior, as clinically assessed by the Investigator
  • Have aggressive behavior and excited , restless
  • History or current symptoms of tardive dyskinesia; neuroleptic malignant syndrome; evidence of dysfunction of liver and kidney and other severe physical diseases; and severe, life-threatening allergic reaction to any drug
  • Known hypersensitivity to risperidone
  • Female participant who is pregnant or breastfeeding or planning to become pregnant during the study period

Key Trial Info

Start Date :

January 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2009

Estimated Enrollment :

640 Patients enrolled

Trial Details

Trial ID

NCT01894984

Start Date

January 1 2007

End Date

December 1 2009

Last Update

May 8 2014

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.